Another company in Hong Kong is integrating crypto into its treasury strategy, aiming to leverage it actively rather than merely as an asset.
IVD Medical Holdings has made a substantial investment of $19 million in ether (ETH), strategically placing this digital asset at the heart of its plans to tokenize healthcare assets.
Key Points:
- IVD Medical Holdings’ purchase of ether is aimed at bolstering its healthcare asset tokenization strategy.
- The firm intends to utilize Ethereum for confirmation of on-chain ownership and for automating revenue distributions.
- This initiative goes hand in hand with a strategic alliance with HashKey Group, enhancing its crypto treasury in alignment with other Hong Kong-based publicly listed companies.
The firm is developing ivd.xyz, a platform dedicated to the tokenization of pharmaceutical intellectual properties and other healthcare-related assets, which will operate entirely through Ethereum smart contracts.
In a statement, Gary Deng, Chief Strategy Officer of IVD Medical, indicated that Ethereum was selected as the principal asset because it is recognized as “the world’s most mature smart contract platform,” featuring a strong liquidity profile and institutional acknowledgment, referencing the recent SEC approval for a spot ETH ETF.
IVD plans to use ether to facilitate on-chain ownership verification, automated revenue disbursement, and compliance governance for tokenized assets. It will also be the basis for the company’s forthcoming IVDD stablecoin, facilitating international transactions compliant with both Hong Kong and U.S. regulations. Revenue generated from real-world asset transactions will be automatically converted to ether and stored in the company’s treasury.
Furthermore, IVD aims to apply ether in staking, re-staking, and on-chain derivatives to boost returns and liquidity while ensuring downside protection, positioning IVD among a select group of publicly traded companies in Hong Kong that maintain crypto treasuries.
